作者: Tibor Tot
DOI: 10.1245/S10434-015-4367-9
关键词:
摘要: Background The few publications on <10-mm invasive breast carcinomas have reported worse outcomes for women with human epidermal growth factor receptor 2 (HER2)-positive cancer compared HER2-negative cases and indicated that the high risk of recurrence in HER2-positive is related to grade, hormone negativity, proliferation index tumor component.